Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2020, the company operated approximately 704 patient care clinics, and 112 satellite locations in 46 states and the District of Columbia. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.
IPO Year: 2018
Exchange: NYSE
Website: hanger.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/25/2022 | $24.00 → $18.75 | Buy → Hold | Jefferies |
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
4 - HANGER, INC. (0000722723) (Issuer)
15-12G - HANGER, INC. (0000722723) (Filer)
EFFECT - HANGER, INC. (0000722723) (Filer)
S-8 POS - HANGER, INC. (0000722723) (Filer)
S-8 POS - HANGER, INC. (0000722723) (Filer)
S-8 POS - HANGER, INC. (0000722723) (Filer)
POS AM - HANGER, INC. (0000722723) (Filer)
8-K - HANGER, INC. (0000722723) (Filer)
8-K - HANGER, INC. (0000722723) (Filer)
DEFA14A - HANGER, INC. (0000722723) (Filer)
8-K - HANGER, INC. (0000722723) (Filer)
WASHINGTON, Dec. 1, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Seth R. Frank has joined the company as Vice President, Investor Relations, effective immediately. Reporting to John Johnson, Evolent's Chief Financial Officer, Seth will lead Evolent's investor relations (IR) strategy and oversee its relationships with the investment community. "Seth provides a demonstrated track record of proactive, finance-driven leadership in health care investor relations to Evolent," said Evolent Health Chief Financial Officer John Johnson. "He brings long-ter
Jefferies downgraded Hanger from Buy to Hold and set a new price target of $18.75 from $24.00 previously
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
SC 13G - HANGER, INC. (0000722723) (Subject)
SC 13G/A - HANGER, INC. (0000722723) (Subject)
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2022. Financial Highlights Net revenues were $312.0 million for the three months ended June 30, 2022, compared to $280.8 million for the same period in 2021, reflecting growth of 11.1 percent. Patient Care same clinic revenue growth per day was 6.2 percent during the period. Net income was $10.1 million for the three months ended June 30, 2022, compared to $10.2 million for the same period in 2021. Income from operations was $20.8 million for the quarter compared to $20.1 million for
Total Enterprise Value of Approximately $1.25 Billion Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, which has been unanimously approved by Hanger's Board of Directors, Hanger stockholders will receive $18.75 in cash per share, representing an approximately 29% premium to the 30 calendar day volume-weighted average price (VWAP) ending July 20, 2022, and a total enterprise value of approximately $1.25 billion. Upon completion of the transaction,
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2022 after the stock market closes on Monday, August 8, 2022. Hanger's management team will host a conference call to discuss the second quarter 2022 financial results the following morning on Tuesday, August 9, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 020458. A live webcast, replay of the call and earnings release, will be availa
Company Reports Strong Same Clinic Revenue Growth Trends; Reaffirms Guidance Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the first quarter ended March 31, 2022. Financial Highlights Net revenues were $261.3 million for the three months ended March 31, 2022, compared to $237.5 million for the same period in 2021, reflecting growth of 10.0 percent. Patient Care same clinic revenue growth per day was 6.9 percent during the period with continuing increases in work-in-process levels during the quarter. Net loss was $8.0 million for the three months ended March 31, 2022, compare
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the first quarter and three months ended March 31, 2022 after the stock market closes on Wednesday, May 4, 2022. Hanger's management team will host a conference call to discuss the first quarter 2022 financial results the following morning on Thursday, May 5, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 335781. A live webcast, replay of the call and earnings release, will be availab
No Changes In Results Since February 7th Pre-announcement Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic ("O&P") patient care services and solutions, today announced its final financial results for the fourth quarter and year ended December 31, 2021. Financial Highlights Net revenues were $312.4 million for the three months ended December 31, 2021, compared to $277.3 million for the same period in 2020, reflecting growth of 12.6 percent. Net income was $14.0 million for the three months ended December 31, 2021, compared to $16.1 million for the same period in 2020. Income from operations was $24.9 million for the quarter compared to $29.1 million for the same
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced a preliminary estimate of certain results for the year ended December 31, 2021. The Company also provided its initial financial outlook for the year ended December 31, 2022. Preliminary 2021 Results The Company currently anticipates that its net revenues for the year ended December 31, 2021 will be approximately $1.120 billion, and Adjusted EBITDA for the same period to be approximately $118.9 million. This reflects growth of approximately 12 percent in net revenue and 13 percent in Adjusted EBITDA as compared to the year ended December 31, 2020. The Company's
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the third quarter and nine months ended September 30, 2021. Financial Highlights Net revenue was $289.8 million for the three months ended September 30, 2021, compared to $256.6 million for the same period in 2020, reflecting growth of 12.9 percent. Net income was $21.1 million for the three months ended September 30, 2021, compared to $6.8 million for the same period in 2020. Income from operations was $25.7 million for the quarter compared to $13.1 million for the same period in 2020. Third quarter 2020 GAAP income from operation
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the third quarter and nine months ended September 30, 2021 after the stock market closes on Monday, November 8, 2021. Hanger's management team will host a conference call with the financial community to discuss the financial results the following morning on Tuesday, November 9 at 8:30 a.m. Eastern time. A live webcast, replay of the call and earnings release, will be available on the Company's Investor Relations website: investor.hanger.com. For members of the financial community participating in the conference call: dial 844-200-
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2021. Financial Highlights Net revenue was $280.8 million for the three months ended June 30, 2021, compared to $233.4 million for the same period in 2020, reflecting growth of 20.3 percent. Net income was $10.2 million for the three months ended June 30, 2021, compared to $31.1 million for the same period in 2020. Income from operations was $20.1 million for the quarter compared to $38.9 million for the same period in 2020. Second quarter 2020 GAAP income from operations and net in
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on July 21, 2022, and Hanger's stockholders approved the transaction at a Special Meeting of Stockholders held on September 30, 2022. As a result of the completion of the acquisition, Hanger stockholders will receive $18.75 in cash per share of common stock, and Hanger's common stock will no longer be traded on the New York Stock Exchange (NYSE). Wit
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm. Vinit Asar, Hanger's President and Chief Executive Officer said, "I would like to express my gratitude to the Hanger stockholders for their support today, and throughout this transaction process. The Hanger team is excited about this partnership with Patient Square Capital, and beginning our next chapter as a private company. We believe this collaboration will enable us to accelerate our growth and enhance our
NEW YORK, Sept. 27, 2022 /PRNewswire/ -- Frontier Communications Parent Inc. (NASD: FYBR) will replace The Hain Celestial Group Inc. (NASD:HAIN) in the S&P Midcap 400 and The Hain Celestial Group will replace Hanger Inc. (NYSE:HNGR) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 3. Patient Square Capital, LP. is acquiring Hanger in a deal expected to be completed soon pending final closing conditions. The Hain Celestial Group is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Se
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2022. Financial Highlights Net revenues were $312.0 million for the three months ended June 30, 2022, compared to $280.8 million for the same period in 2021, reflecting growth of 11.1 percent. Patient Care same clinic revenue growth per day was 6.2 percent during the period. Net income was $10.1 million for the three months ended June 30, 2022, compared to $10.2 million for the same period in 2021. Income from operations was $20.8 million for the quarter compared to $20.1 million for
NEW YORK, NY / ACCESSWIRE / August 6, 2022 /Silverback Therapeutics, Inc. (NASDAQ:SBTX)Lifshitz Law PLLC announces an investigation into possible breaches of fiduciary duty in connection with SBTX's merger with ARS Pharmaceuticals, Inc. Under Under the terms of the merger agreement, assuming that Silverback's net cash at closing is $240 million, SBTX's equity holders are expected to own approximately 37% of the combined company.If you are an SBTX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or email at [email protected], Inc. (NYSE:HNGR)Lifshitz Law
Total Enterprise Value of Approximately $1.25 Billion Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, which has been unanimously approved by Hanger's Board of Directors, Hanger stockholders will receive $18.75 in cash per share, representing an approximately 29% premium to the 30 calendar day volume-weighted average price (VWAP) ending July 20, 2022, and a total enterprise value of approximately $1.25 billion. Upon completion of the transaction,
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2022 after the stock market closes on Monday, August 8, 2022. Hanger's management team will host a conference call to discuss the second quarter 2022 financial results the following morning on Tuesday, August 9, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 020458. A live webcast, replay of the call and earnings release, will be availa
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that members of its management team will participate in presentations and meetings at the Jefferies Healthcare Conference taking place June 8-10, 2022. Members of Hanger management will participate in a presentation scheduled for Thursday, June 9, beginning at 10:30 a.m. Eastern time. The conference presentation and replay of the webcast will be available on the investor relations section of the Company's website at investor.hanger.com. About Hanger, Inc. – Headquartered in Austin, Texas, Hanger, Inc. (NYSE:HNGR) provides comprehensive, outcomes-based orthotic
Company Reports Strong Same Clinic Revenue Growth Trends; Reaffirms Guidance Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the first quarter ended March 31, 2022. Financial Highlights Net revenues were $261.3 million for the three months ended March 31, 2022, compared to $237.5 million for the same period in 2021, reflecting growth of 10.0 percent. Patient Care same clinic revenue growth per day was 6.9 percent during the period with continuing increases in work-in-process levels during the quarter. Net loss was $8.0 million for the three months ended March 31, 2022, compare
Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the first quarter and three months ended March 31, 2022 after the stock market closes on Wednesday, May 4, 2022. Hanger's management team will host a conference call to discuss the first quarter 2022 financial results the following morning on Thursday, May 5, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 335781. A live webcast, replay of the call and earnings release, will be availab